Home › Funds › PARADIGM CAPITAL MANAGEMENT INC/NY › XRAY

PARADIGM CAPITAL MANAGEMENT INC/NY position in XRAY

DENTSPLY SIRONA INC · Health Care

PARADIGM CAPITAL MANAGEMENT INC/NY reported holding 3,989,800 shares of XRAY (DENTSPLY SIRONA INC) in its Q3 2026 13F filing — a position valued at US$35.3M, representing 1.12% of its reported portfolio and ranking #21 among its reported holdings. PARADIGM CAPITAL MANAGEMENT INC/NY has disclosed XRAY holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)3.99M sh
Reported value held$35.35M
Portfolio Weight1.12%
First reportedQ3 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PARADIGM CAPITAL MANAGEMENT INC/NY's XRAY position evolved

PARADIGM CAPITAL MANAGEMENT INC/NY first disclosed a stake in XRAY in Q3 2025 at 942,251 shares (US$12.0M). The position peaked in Q2 2026 at 3,748,800 shares, worth US$39.8M. Across 5 filings, PARADIGM CAPITAL MANAGEMENT INC/NY increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,989,800 shares valued at US$35.3M — an increase of 241,000 shares quarter over quarter.. Notable position changes include a 155% increase in Q4 2025 (shares rose 1% over the following quarter), a 26% increase in Q2 2026 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 942.25K $11.96M New
Q4 2025 2.40M $27.41M Add
Q1 2026 2.98M $34.54M Add
Q2 2026 3.75M $39.77M Add
Q3 2026 3.99M $35.35M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XRAY and 13F data

XRAY (DENTSPLY SIRONA INC) is a Health Care company. 12 other funds we track also report a position in XRAY — the largest reported positions include ARIEL INVESTMENTS, LLC (US$77.0M), Southpoint Capital Advisors LP (US$74.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XRAY

All XRAY fund holders →

FAQ

How long has PARADIGM CAPITAL MANAGEMENT INC/NY held XRAY?

PARADIGM CAPITAL MANAGEMENT INC/NY has disclosed XRAY holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is PARADIGM CAPITAL MANAGEMENT INC/NY's current position in XRAY?

As of Q3 2026, PARADIGM CAPITAL MANAGEMENT INC/NY holds 3.99M shares of XRAY (DENTSPLY SIRONA INC), valued at $35.35M, representing 1.12% of its reported portfolio and ranking #21.

Has PARADIGM CAPITAL MANAGEMENT INC/NY been buying or selling XRAY?

In the latest 13F filing (Q3 2026), PARADIGM CAPITAL MANAGEMENT INC/NY increased its position in XRAY. The position peaked in Q2 2026 at 3.75M shares.

Which other funds hold XRAY?

Other major institutional holders of XRAY include ARIEL INVESTMENTS, LLC, Southpoint Capital Advisors LP, among 12 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.